Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers (Narrative) (Details)

v3.21.2
Revenues from Contracts and Significant Customers (Narrative) (Details)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
product
Jun. 30, 2020
USD ($)
Dec. 31, 2020
Disaggregation of Revenue [Line Items]          
Number of marketed products | product     7    
Revenue from Contract with Customer, Including Assessed Tax | $ $ 15,288 $ 9,415 $ 26,007 $ 21,361  
Dermatology Products Sales [Member] | Customer one [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]          
Disaggregation of Revenue [Line Items]          
Concentration risk, percentage     13.70%   12.00%